Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
SOPH Chief Scientific Officer Xu Zhenyu Sells 608 Shares
What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in an open-market transaction on March 19, 2026. The weighted-average price reported was $4.78 per share (range $4.715–$4.87), for total proceeds of approximately $2,907. This sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units and was part of a pre-established Rule 10b5-1 trading plan, not a discretionary trade.
Key Details
- Transaction date: 2026-03-19 (Form 4 filed 2026-03-20 — timely filing)
- Shares sold: 608 shares; weighted-average price $4.78; price range $4.715–$4.87
- Total proceeds: ~$2,907
- Reason/footnotes: Sale to cover tax obligations from RSU vesting on 2026-03-18; executed under a pre-established Rule 10b5-1 plan (non-discretionary) (F1).
- Price disclosure: Column 4 is weighted average; reporter can provide per-trade breakdown on request (F2).
- Shares owned after transaction: Not specified in the provided excerpt.
Context
Sales to cover tax withholding for vested RSUs are routine and common for insiders and do not necessarily signal a change in sentiment about the company. The amount here is small (~$2.9k) and was conducted under a pre-set 10b5-1 plan, which generally indicates the trades were planned in advance rather than timed based on current company information.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-03-19$4.78/sh−608$2,907→ 537,116 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax obligations arising in connection with the vesting of restricted stock units on March 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.715 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.